Skip to main content
Caplight Logo









AtoGen Co., Ltd.

AtoGen Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://atogen.kr/

Last Round

Strategic

Sep 15, 2022

Total Funding Raised

$14.06M

Company Overview

AtoGen Co., Ltd. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Strategic round in September 2022.

AtoGen Co., Ltd. is a biotechnology company that develops microbiome-based therapeutics and functional health ingredients using a proprietary screening platform and genomic analysis technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AtoGen Co., Ltd. Comparables

Compare AtoGen Co., Ltd. with similar companies based on industry and business-model similarity.

AtoGen Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enterobiome Inc.
80%
KoBioLabs Inc
79%
GI Longevity
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AtoGen Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 15, 2022
VC RoundJan 3, 2022
Series AJan 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2020

    $7M round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

AtoGen Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

AtoGen Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AtoGen Co., Ltd.'s valuation, stock price, and market status.

Is AtoGen Co., Ltd. a public or private company?

AtoGen Co., Ltd. is a private company.

What is the current stock price of AtoGen Co., Ltd.?

AtoGen Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks AtoGen Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AtoGen Co., Ltd. worth (valuation)?

Valuation information for AtoGen Co., Ltd. is not publicly available.

Can I buy AtoGen Co., Ltd. stock?

AtoGen Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AtoGen Co., Ltd.'s last funding round?

AtoGen Co., Ltd.'s most recent funding round was Strategic on September 15, 2022.

Who are the main investors in AtoGen Co., Ltd.?

Investor information for AtoGen Co., Ltd. is not publicly disclosed.

Will AtoGen Co., Ltd. IPO soon?

No public IPO plans have been announced for AtoGen Co., Ltd..

How can I track AtoGen Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in AtoGen Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersDaejeon
Year Founded2010
Last FundingSep 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?